MIFH
AMAM

Migdal Insurance & Financial Holdings’s Ambrx Biopharma Inc AMAM Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-124
Closed -$1K – 714
2021
Q4 		$1K Sell
124
-76
-38% -$848 ﹤0.01% 680
2021
Q3 		$3K Buy
+200
New +$3.6K ﹤0.01% 650

Other funds holding AMAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Migdal Insurance & Financial Holdings's AMAM Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Ambrx Biopharma Inc (AMAM) in Q1 2022, closing a stake of 124 shares — an estimated $1K sold.

Migdal Insurance & Financial Holdings first reported a position in AMAM in Q3 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 14 funds tracked by Wall St. Rank hold AMAM as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Ambrx Biopharma Inc position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 124 Ambrx Biopharma Inc shares in Q1 2022, an estimated $1K.
  • Migdal Insurance & Financial Holdings first reported a position in Ambrx Biopharma Inc in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Ambrx Biopharma Inc position peaked at $3K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.